Compass Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-480,513
| Closed | -$49.7M | – | 36 |
|
|
2021
Q4 | $49.7M | Buy |
480,513
+75,574
| +19% | +$8.75M | 3.33% | 25 |
|
|
2021
Q3 | $50.8M | Buy |
404,939
+3,023
| +0.8% | +$391K | 3.91% | 13 |
|
|
2021
Q2 | $49.9M | Buy |
401,916
+14,065
| +4% | +$1.77M | 3.82% | 15 |
|
|
2021
Q1 | $45.8M | Buy |
387,851
+6,292
| +2% | +$737K | 3.88% | 16 |
|
|
2020
Q4 | $44.7M | Buy |
381,559
+8,644
| +2% | +$952K | 3.92% | 13 |
|
|
2020
Q3 | $38.8M | Buy |
372,915
+20,562
| +6% | +$2.06M | 3.75% | 17 |
|
|
2020
Q2 | $32.3M | Buy |
352,353
+23,615
| +7% | +$2.26M | 3.54% | 24 |
|
|
2020
Q1 | $29.6M | Buy |
328,738
+1,447
| +0.4% | +$154K | 3.83% | 17 |
|
|
2019
Q4 | $37.1M | Buy |
327,291
+5,888
| +2% | +$646K | 4.01% | 11 |
|
|
2019
Q3 | $34.9M | Sell |
321,403
-16,757
| -5% | -$1.75M | 4.08% | 10 |
|
|
2019
Q2 | $32.9M | Buy |
+338,160
| New | +$30.9M | 3.92% | 12 |
|
|
2019
Q1 | – | Sell |
-316,753
| Closed | -$28.8M | – | 42 |
|
|
2018
Q4 | $28.8M | Buy |
316,753
+4,407
| +1% | +$412K | 4.1% | 8 |
|
|
2018
Q3 | $30.7M | Sell |
312,346
-5,368
| -2% | -$496K | 4.03% | 10 |
|
|
2018
Q2 | $27.2M | Buy |
+317,714
| New | +$26.5M | 3.96% | 12 |
|
|
2018
Q1 | – | Sell |
-302,793
| Closed | -$24.5M | – | 42 |
|
|
2017
Q4 | $24.5M | Buy |
302,793
+12,871
| +4% | +$1.03M | 3.7% | 22 |
|
|
2017
Q3 | $22.5M | Buy |
+289,922
| New | +$24.1M | 3.58% | 24 |
|
|
2016
Q2 | – | Sell |
-249,524
| Closed | -$18.7M | – | 44 |
|
|
2016
Q1 | $18.7M | Buy |
+249,524
| New | +$18.8M | 3.73% | 19 |
|
|
2015
Q3 | – | Sell |
-254,316
| Closed | -$18.8M | – | 45 |
|
|
2015
Q2 | $18.8M | Buy |
+254,316
| New | +$19.4M | 3.98% | 11 |
|
|
2015
Q1 | – | Sell |
-257,528
| Closed | -$18.6M | – | 48 |
|
|
2014
Q4 | $18.6M | Sell |
257,528
-18,672
| -7% | -$1.3M | 3.97% | 9 |
|
|
2014
Q3 | $17.1M | Sell |
276,200
-4,401
| -2% | -$280K | 3.29% | 11 |
|
|
2014
Q2 | $17.9M | Buy |
280,601
+3,817
| +1% | +$232K | 3.46% | 2 |
|
|
2014
Q1 | $17M | Sell |
276,784
-2,580
| -0.9% | -$150K | 3.4% | 5 |
|
|
2013
Q4 | $16M | Buy |
279,364
+1,777
| +0.6% | +$101K | 3.23% | 11 |
|
|
2013
Q3 | $14.8M | Sell |
277,587
-460
| -0.2% | -$24.8K | 3.33% | 8 |
|
|
2013
Q2 | $14.3M | Buy |
+278,047
| New | +$13.7M | 3.48% | 2 |
|
Other funds holding MDT
WA
Compass Capital Management's MDT Position: Q1 2022 in Review
Compass Capital Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 480,513 shares — an estimated $49.7M sold.
Compass Capital Management first reported a position in MDT in Q2 2013 and held it in 25 quarters. The position peaked at $50.8M in Q3 2021. 2,102 funds tracked by Wall St. Rank hold MDT as of Q1 2022.
- Compass Capital Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
- Compass Capital Management sold 480,513 Medtronic shares in Q1 2022, an estimated $49.7M.
- Compass Capital Management first reported a position in Medtronic in Q2 2013 and held it in 25 quarters.
- Compass Capital Management's Medtronic position peaked at $50.8M in Q3 2021.
- 2,102 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.
Based on Compass Capital Management's 13F filing for Q1 2022, filed 6 May 2022.